KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInvested Capital

AbCellera Biologics (ABCL) Return on Assets (2021 - 2023)

Historic Return on Assets for AbCellera Biologics (ABCL) over the last 4 years, with Q3 2024 value amounting to 0.03%.

  • AbCellera Biologics' Return on Assets rose 500.0% to 0.03% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.03%, marking a year-over-year increase of 500.0%. This contributed to the annual value of 0.11% for FY2024, which is 200.0% down from last year.
  • AbCellera Biologics' Return on Assets amounted to 0.03% in Q3 2024, which was up 500.0% from 0.05% recorded in Q2 2024.
  • In the past 5 years, AbCellera Biologics' Return on Assets registered a high of 0.26% during Q1 2021, and its lowest value of 0.1% during Q4 2023.
  • For the 4-year period, AbCellera Biologics' Return on Assets averaged around 0.06%, with its median value being 0.1% (2022).
  • In the last 5 years, AbCellera Biologics' Return on Assets crashed by -2400bps in 2023 and then surged by 500bps in 2024.
  • Over the past 4 years, AbCellera Biologics' Return on Assets (Quarter) stood at 0.12% in 2021, then fell by -17bps to 0.1% in 2022, then plummeted by -195bps to 0.1% in 2023, then soared by 66bps to 0.03% in 2024.
  • Its Return on Assets was 0.03% in Q3 2024, compared to 0.05% in Q2 2024 and 0.07% in Q1 2024.